Researchers have developed a personalized neurological footprint, which uses a link between brain physiology, genetic profile and response to therapeutics, to predict the effectiveness of aiming treatment at various targets within individual patients.
Stem cells and brain organoids were the focus of a symposium during the FENS Forum of Neuroscience (7–11 July, Berlin,…
Scientists have demonstrated how variations in a gene linked to anxiety and depression could affect a patient’s response to treatment.
Research has demonstrated that traumatic effects caused by a stressful experience can lead to epigenetic changes to gene activity; these changes can be passed on, and therefore result in behavioral changes in future generations.
In an international collaboration, researchers have determined that psychiatric disorders may have important molecular similarities that are not reflected in current diagnostic categories.
A novel study reveals that the placenta could play an imperative role in schizophrenia and possibly other neurodevelopmental disorders.
Researchers have uncovered three new genes that are linked to the possibility of developing Alzheimer’s disease; potentially unlocking new treatment possibilities for patients.
A research team has identified a gene that, upon elimination, could potentially spur regeneration of axons in nerve cells severed by spinal cord injury.
Clinical trial announcements, orphan-drug designation and more: check out our round-up of the biggest news from the neuroscience and neurology industries this week.
For the first time, researchers have discovered that non-gene mutations could cause rare developmental disorders of the CNS.